129 related articles for article (PubMed ID: 12713075)
1. Angiotensin-converting enzyme gene polymorphism and erythropoietin requirement.
Varagunam M; McCloskey DJ; Sinnott PJ; Raftery MJ; Yaqoob MM
Perit Dial Int; 2003; 23(2):111-5. PubMed ID: 12713075
[TBL] [Abstract][Full Text] [Related]
2. The effect of proinflammatory cytokine gene and angiotensin-converting enzyme polymorphisms on erythropoietin requirements in patients on continuous ambulatory peritoneal dialysis.
Sharples EJ; Varagunam M; Sinnott PJ; McCloskey DJ; Raftery MJ; Yaqoob MM
Perit Dial Int; 2006; 26(1):64-8. PubMed ID: 16538877
[TBL] [Abstract][Full Text] [Related]
3. Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis.
Wei M; Bargman JM; Oreopoulos DG
Int Urol Nephrol; 2007; 39(3):935-40. PubMed ID: 17534732
[TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin therapy in chronic dialysis patients.
Charytan C; Goldfarb-Rumyantzev A; Wang YF; Schwenk MH; Spinowitz BS
Am J Nephrol; 1998; 18(6):498-503. PubMed ID: 9845824
[TBL] [Abstract][Full Text] [Related]
5. Increased erythropoietin requirements in patients with failed renal transplants returning to a dialysis programme.
Almond MK; Tailor D; Marsh FP; Raftery MJ; Cunningham J
Nephrol Dial Transplant; 1994; 9(3):270-3. PubMed ID: 8052433
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin dosage in children undergoing hemodialysis and continuous ambulatory peritoneal dialysis.
Sieniawska M; Roszkowska-Blaim M
Pediatr Nephrol; 1997 Oct; 11(5):628-30. PubMed ID: 9323294
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin in continuous ambulatory peritoneal dialysis: experience with subcutaneous administration.
Eisele G; Bailie GR; Clement C; Wong E
Perit Dial Int; 1992; 12(1):34-6. PubMed ID: 1543777
[TBL] [Abstract][Full Text] [Related]
8. The predictive parameters of erythropoietin hyporesponsiveness in patients on continuous ambulatory peritoneal dialysis.
Kim JK; Park BS; Park MJ; Choi W; Ma SK; Nah MY; Yeum CH; Jung K; Lee SC; Kim SW; Kim NH; Kang YJ; Choi KC
Korean J Intern Med; 2001 Jun; 16(2):110-7. PubMed ID: 11590897
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of intraperitoneal erythropoietin administered undiluted or diluted in dialysate.
Bargman JM; Jones JE; Petro JM
Perit Dial Int; 1992; 12(4):369-72. PubMed ID: 1420495
[TBL] [Abstract][Full Text] [Related]
10. Role of ACE and IL-1β Gene Polymorphisms in Erythropoeitin Hyporesponsive Patients with Chronic Kidney Disease with Anemia.
Nand N; Deshmukh AR; Joshi S; Sachdeva MP; Sakthivel
J Assoc Physicians India; 2017 Feb; 65(2):32-36. PubMed ID: 28457029
[TBL] [Abstract][Full Text] [Related]
11. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD.
Bunke M; Bartlett DK; Brier ME; Golper TA
Adv Perit Dial; 1993; 9():331-5. PubMed ID: 8105957
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD.
Icardi A; Paoletti E; Molinelli G
Adv Perit Dial; 1990; 6():292-5. PubMed ID: 1982830
[TBL] [Abstract][Full Text] [Related]
13. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Vale L; Wallace S; MacLeod A
Cochrane Database Syst Rev; 2002; (4):CD003895. PubMed ID: 12519614
[TBL] [Abstract][Full Text] [Related]
14. [A study on angiotensin-I converting enzyme polymorphism in CAPD patients].
Nishina M
Nihon Jinzo Gakkai Shi; 1996 Dec; 38(12):595-602. PubMed ID: 9014479
[TBL] [Abstract][Full Text] [Related]
15. [The effects of ACE inhibitor treatment and ACE gene polymorphism on erythropoiesis in chronic hemodialysis patients].
Hatano M; Yoshida T; Mimuro T; Kimata N; Tsuchiya K; Sanaka T; Nihei H
Nihon Jinzo Gakkai Shi; 2000 Oct; 42(8):632-9. PubMed ID: 11195399
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: any evidence of erythropoietin resistance?
Cruz DN; Perazella MA; Abu-Alfa AK; Mahnensmith RL
Am J Kidney Dis; 1996 Oct; 28(4):535-40. PubMed ID: 8840943
[TBL] [Abstract][Full Text] [Related]
18. Treatment of anaemia in CAPD patients with recombinant human erythropoietin.
Ramello A; Malcangi U; Bruno M; Perosa P; Reina E; Rizzuto A; Nasini MG; Carozzi S
Adv Perit Dial; 1990; 6():308-11. PubMed ID: 1982834
[TBL] [Abstract][Full Text] [Related]
19. ACE inhibitors or angiotensin II receptor blockers in dialysed patients and erythropoietin resistance.
Saudan P; Halabi G; Perneger T; Wasserfallen JB; Wauters JP; Martin PY;
J Nephrol; 2006; 19(1):91-6. PubMed ID: 16523432
[TBL] [Abstract][Full Text] [Related]
20. Inflammation, peritoneal transport, and response to erythropoietin in peritoneal dialysis patients.
Pilkey RM; Morton AR; Iliescu EA
Adv Perit Dial; 2001; 17():153-7. PubMed ID: 11510266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
